GeneCopoeia is the industry leader in expression-ready ORF cDNA clones, and we also carry reporter plasmid clones carrying gene promoters and 3′ UTR microRNA (miRNA) binding site targets. OmicsLink™ SARS-CoV-2-related ORF cDNA plasmid clones can be constructed in any of our more than 250 ready-to-go vector types expressing both SARS-CoV-2 viral proteins as well as host proteins, which you can select using the drop-down menus below.
OmicsLink™ SARS-CoV-2-related ORF cDNA plasmid clones are part of GeneCopoeia’s COVID-19 Coronavirus Research Tools products.
Note: SARS-CoV-2-related ORF cDNA plasmid clones are for research purposes only. They are not intended for diagnostic or treatment usage in humans.
We also have OmicsLink™ ORF cDNA plasmid clones for the related virus SARS-CoV-1, which caused the 2002-2004 SARS outbreak.
Order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral Spike proteins
To order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral Spike proteins in one of our more than 250 non-viral and lentiviral vector types, select the product ID from the table below and contact inquiry@genecopoeia.com.To view the Spike mutations in each Spike variant, refer to the table “Spike variant mutational profiles” below.
| Product ID | Protein accession | Symbol | Alias | Spike genotype | Description |
|---|---|---|---|---|---|
| NV219 | YP_009724390.1 | S | GU280_gp02 | WT | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene (codon optimized) |
| NV236 | YP_009724390.1 | S | GU280_gp02 | D614G | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G mutation (codon optimized) |
| NV237 | YP_009724390.1 | S | GU280_gp02 | N439K | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with N439K mutation (codon optimized) |
| NV238 | YP_009724390.1 | S | GU280_gp02 | D614G, N439K | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with N439K, D614G mutations (codon optimized) |
| NV239 | YP_009724390.1 | S | GU280_gp02 | D614G, E501Y | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, E501Y mutations (codon optimized) |
| NV240 | YP_009724390.1 | S | GU280_gp02 | D614G, P681H | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, P681H mutations (codon optimized) |
| NV241 | YP_009724390.1 | S | GU280_gp02 | D614G, Hv69-90deletion | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, Hv69-90deletion mutations (codon optimized) |
| NV242 | YP_009724390.1 | S | GU280_gp02 | D614G, U.K. B.1.1.7 | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, U.K. B.1.1.7 mutations (codon optimized) |
| NV244 | YP_009724390.1 | S | GU280_gp02 | D614G, South Africa B.1.351 | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, South Africa B.1.351 mutations (codon optimized) |
| NV245 | YP_009724390.1 | S | GU280_gp02 | D614G, Brazil P.1 | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, Brazil P.1 mutations (codon optimized) |
| NV247 | YP_009724390.1 | S | GU280_gp02 | California B.1.427/B.1.429 | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with California B.1.427/B.1.429 mutations (codon optimized) |
| NV248 | YP_009724390.1 | S | GU280_gp02 | India B.1.617 | surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with India B.1.617 mutations (codon optimized) |
| NV220 | YP_009724390.1 | S1 | GU280_gp02 | WT | surface glycoprotein subunit 1 [Severe acute respiratory syndrome coronavirus 2], mature peptide (codon optimized) |
| NV221 | YP_009724390.1 | S2 | GU280_gp02 | WT | surface glycoprotein subunit 2 [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized) |
| NV222 | YP_009724390.1 | RBD | GU280_gp02 | WT | Receptor binding domain [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized) |
Spike variant mutational profiles
At the time of product introduction, GeneCopoeia’s R&D team used the GISAID database to determine the most frequently-occurring mutations in the Spike proteins from each variant to incorporate into our Spike-expressing ORF clones. These mutational profiles are indicated below. Note that each variant can have different sub-lineages, which could contain a slightly different repertoire of mutations from the variants that we have made available. If you would like SARS-CoV-2 Spike-expressing ORF clones with a different set of mutations than we have currently available. please contact inquiry@genecopoeia.com for a custom project.
| SARS-CoV-2 variant | Spike mutations |
|---|---|
| Wild type (product IDs NV219, NV220, NV221, NV222) | None |
| D614G (product ID NV236) | D614G |
| N439K (product ID NV237) | N439K |
| N439K & D614G (product ID NV238) | N439K, D614G |
| N439K & N501Y (product ID NV239) | N439K, N501Y |
| D614G & P681H (product ID NV240) | D614G, P681H |
| D614G & Hv69-90deletion (product ID NV241) | Δ69-70, D614G |
| B.1.1.7 (first identified in the U.K.; product ID NV242) | Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H |
| B.1.351 (first identified in South Africa; product ID NV244) | L18F, D80A, D215G,Δ242-244, K417N, E484K, N501Y, D614G, A701V |
| P.1 (first identified in Brazil; product ID NV245) | L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F |
Order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral proteins
To order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral proteins in one of our more than 250 non-viral and lentiviral vector types, select the product ID from the table below and contact inquiry@genecopoeia.com.| Product ID | Protein accession | Symbol | Alias | Description |
|---|---|---|---|---|
| NV201 (please inquire) | YP_009724389.1 | orf1ab | GU280_gp01 | orf1ab polyprotein [Severe acute respiratory syndrome coronavirus 2}, full-length gene |
| NV202 | YP_009725297.1 | orf1ab | GU280_gp01 | leader protein [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV203 | YP_009725298.1 | orf1ab | GU280_gp01 | nsp2n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV204 | YP_009725299.1 | orf1ab | GU280_gp01 | nsp3n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV205 | YP_009725300.1 | orf1ab | GU280_gp01 | nsp4n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV206 | YP_009725301.1 | orf1ab | GU280_gp01 | 3C-like proteinase [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV207 | YP_009725302.1 | orf1ab | GU280_gp01 | nsp6n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV208 | YP_009725303.1 | orf1ab | GU280_gp01 | nsp7n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV209 | YP_009725304.1 | orf1ab | GU280_gp01 | nsp8n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV210 | YP_009725305.1 | orf1ab | GU280_gp01 | nsp9n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV211 | YP_009725306.1 | orf1ab | GU280_gp01 | nsp10n [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV212 | YP_009725307.1 | orf1ab | GU280_gp01 | RNA-dependent RNA polymerase [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV213 | YP_009725308.1 | orf1ab | GU280_gp01 | helicase [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV214 | YP_009725309.1 | orf1ab | GU280_gp01 | 3′-to-5′ exonuclease [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV215 | YP_009725310.1 | orf1ab | GU280_gp01 | endoRNAse [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV216 | YP_009725311.1 | orf1ab | GU280_gp01 | 2′-O-ribose methyltransferase [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV217 (please inquire) | YP_009725295.1 | orf1a | GU280_gp01 | orf1a polyprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV218 | YP_009725312.1 | orf1a | GU280_gp01 | produced by pp1a only [Severe acute respiratory syndrome coronavirus 2], mature peptide* |
| NV223 | YP_009724391.1 | ORF3a | GU280_gp03 | ORF3a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV224 | YP_009724392.1 | E | GU280_gp04 | envelope protein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV225 | YP_009724393.1 | M | GU280_gp05 | membrane glycoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV226 | YP_009724394.1 | ORF6 | GU280_gp06 | ORF6 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV227 | YP_009724395.1 | ORF7a | GU280_gp07 | ORF7a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV228 | YP_009725318.1 | ORF7b | GU280_gp08 | ORF7b [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV229 | YP_009724396.1 | ORF8 | GU280_gp09 | ORF8 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV230 | YP_009724397.2 | N | GU280_gp10 | nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
| NV231 | YP_009725255.1 | ORF10 | GU280_gp11 | ORF10 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene |
*Note: Mature peptides are produced as a result of proteolytic processing of larger precursor proteins. To enable expression of these proteins in cells, an ATG has been added to the 5′ end of the ORF sequence.
For more information or to request a quote, please contact inquiry@genecopoeia.com.
You can purchase ORF cDNA clones expressing human host proteins that SARS-CoV-2 interacts with, including ACE2, which encodes the receptor for SARS-CoV-2 on respiratory epithelial cells, in more than 250 non-viral and lentiviral vector types. Either view all standard clones using the buttons below, or choose human clones in several popular vector types in the table. If you don’t see what you need here, please contact inquiry@genecopoeia.com.
View all ACE2 ORF cDNA clones for human, mouse, and rat
![]() |
![]() |
![]() |
Order human ACE2 ORF cDNA clones in popular vector types
Clones in yellow shading are available for next-day shipping in bacterial stock format.** |
For more information or to request a quote, please contact inquiry@genecopoeia.com.
** Next-day shipping is available for NextDay ORF clones in bacterial stock format. Lead times for NextDay ORF clones in purified plasmid is ~3-5 days. Orders for NextDay ORF clones must be received by 12PM EST Mon-Thurs in order to be processed and shipped the next day.You can purchase ORF cDNA clones expressing human host proteins that SARS-CoV-2 interacts with, including TMPRSS2, a serine protease required for S protein priming, in more than 250 non-viral and lentiviral vector types. Either view all standard clones using the buttons below, or choose human clones in several popular vector types in the table. If you don’t see what you need here, please contact inquiry@genecopoeia.com.
View all TMPRSS2 ORF cDNA clones for human, mouse, and rat
![]() |
![]() |
![]() |
Order human TMPRSS2 ORF cDNA clones in popular vector types
Clones in yellow shading are available for next-day shipping in bacterial stock format.** |
For more information or to request a quote, please contact inquiry@genecopoeia.com.
** Next-day shipping is available for NextDay ORF clones in bacterial stock format. Lead times for NextDay ORF clones in purified plasmid is ~3-5 days. Orders for NextDay ORF clones must be received by 12PM EST Mon-Thurs in order to be processed and shipped the next day.The cyclophilins are a family of proline isomerases that function to aid in protein folding. Cyclophilins bind to the immunosuppressive drug cyclosporin A (CsA) and help mediate CsA’s pharmacological function. While there is no published evidence yet that cyclophilins are involved in the pathogenesis of SARS-CoV-2, several groups have shown that CsA can inhibit several viruses, including the virus that caused the 2002-2004 SARS pandemic, SARS-CoV, in a cyclophilin A (CypA)-dependent fashion (reviewed in Tanaka, Y., et al., 2013. Viruses 5, 1,250). Further, CypA interacts with SARS-CoV Non-structural protein 1 (Nsp1) as demonstrated in a yeast 2-hybrid screen (Pfefferle, E., et al.. 2011; PLOS Pathogens doi: doi:10.1371/journal.ppat.1002331). SARS-CoV is highly similar to SARS-CoV-2, and, in fact, both viruses use ACE2 as their cellular receptor. Therefore, it is reasonable to include CypA in investigations of a potential role for CypA in SARS-CoV-2 pathogenesis.
GeneCopoeia provides non-viral and lentiviral ORF cDNA clones in 250+ vector types for CYPA in human, mouse, and rat.
View all human cyclophilin A ORF cDNA clones
Humans have two known isoforms of cyclophilin A (PPIA). You can order human cyclophilin ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below
| Product ID | Accession | Symbol | Alias | Description |
|---|---|---|---|---|
| F0323 | NM_021130.4 | PPIA | CYPA, CYPH, HEL-S-69p | Homo sapiens peptidylprolyl isomerase A (PPIA), transcript variant 1, mRNA. |
| T2782 | NM_001300981.1 | PPIA | CYPA, CYPH, HEL-S-69p | Homo sapiens peptidylprolyl isomerase A (PPIA), transcript variant 2, mRNA. |
View all mouse M. musculus cyclophilin A ORF cDNA clones
Mouse M. musculus has only one known isoform of cyclophilin A (PPIA). You can order mouse cyclophilin A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below.
| Product ID | Accession | Symbol | Alias | Description |
|---|---|---|---|---|
| Mm17577 | NM_008907.1 | Ppia | 2700098C05, Cphn, CyP-18, CypA | Mus musculus peptidylprolyl isomerase A (Ppia), mRNA. |
View all rat R. norvegicus cyclophilin A ORF cDNA clones
Rat R. norvegicus has only one known isoform of cyclophilin A (PPIA). You can order rat cyclophilin A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below.
| Product ID | Accession | Symbol | Alias | Description |
|---|---|---|---|---|
| Rn24256 | NM_017101.1 | Ppia | CYCA, CyP-A | Rattus norvegicus peptidylprolyl isomerase A (Ppia), mRNA. |
FK506 binding proteins (FKBP) are, like cyclophilins, proline isomerases that bind to another immunosuppressive drug, FK506 and mediate its pharmacology. While there is no published evidence yet that FKBPs are involved in the pathogenesis of SARS-CoV-2, several groups have demonstrated that FKBP1A is important for assembly of the virus that caused the 2002-2004 SARS pandemic, SARS-CoV (Pfefferle, S., et al., 2011; PLOS Pathogens doi: 10.1371/journal.ppat.1002331). SARS-CoV is highly similar to SARS-CoV-2, and, in fact, both viruses use ACE2 as their cellular receptor. Therefore, it is reasonable to include FKBP1A in investigations of a potential role for FKBP1A in SARS-CoV-2 pathogenesis.
GeneCopoeia provides non-viral and lentiviral ORF cDNA clones in 250+ vector types for FKBP1A in human, mouse, and rat.
View all human FKBP1A ORF cDNA clones
Humans have two known isoforms of FKBP1A. You can order human FKBP1A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below
| Product ID | Accession | Symbol | Alias | Description |
|---|---|---|---|---|
| R0062 | NM_000801.4 | FKBP1A | FKBP-12, FKBP-1A, FKBP1, FKBP12, PKC12, PKCI2, PPIASE | Homo sapiens FK506 binding protein 1A (FKBP1A), transcript variant 1, mRNA. |
| Z8544 | NM_001199786.1 | FKBP1A | FKBP-12, FKBP-1A, FKBP1, FKBP12, PKC12, PKCI2, PPIASE | Homo sapiens FK506 binding protein 1A (FKBP1A), transcript variant 3, mRNA. |
View all mouse M. musculus FKBP1A ORF cDNA clones
Mouse M. musculus has four known isoforms of FKBP1A. You can order mouse FKBP1A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below.
| Product ID | Accession | Symbol | Alias | Description |
|---|---|---|---|---|
| Mm02519 | NM_008019.2 | Fkbp1a | 12kDa, FKBP12, FKBP12-T1, FKBP12-T2, Fkbp, Fkbp1, mFKBP1, mFKBP12 | Mus musculus FK506 binding protein 1a (Fkbp1a), mRNA. |
| Mm38146 | NM_001302078.1 | Fkbp1a | FKBP12, Fkbp, Fkbp1 | Mus musculus FK506 binding protein 1a (Fkbp1a), transcript variant 4, mRNA. |
| Mm38147 | NM_001302079.1 | Fkbp1a | FKBP12, Fkbp, Fkbp1 | Mus musculus FK506 binding protein 1a (Fkbp1a), transcript variant 5, mRNA. |
| Mm38985 | NM_001355078.1 | Fkbp1a | FKBP12, Fkbp, Fkbp1 | Mus musculus FK506 binding protein 1a (Fkbp1a), transcript variant 8, mRNA. |
View all rat R. norvegicus FKBP1A ORF cDNA clones
Rat R. norvegicus has only one known isoform of FKBP1A. You can order rat FKBP1A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below.
| Product ID | Accession | Symbol | Alias | Description |
|---|---|---|---|---|
| Rn24112 | NM_013102.3 | Fkbp1a | FKBP12, Fkbp2 | Rattus norvegicus FKBP prolyl isomerase 1A (Fkbp1a), mRNA. |
A recent publication in Nature (Gordon, et al., 2020) described the results of an affinity purification-mass spectrometry (AP-MS) screen that identified 332 human proteins that physically interact with 26 SARS-CoV-2 viral proteins. While it is unlikely that all 332 interactions are physiologically relevant, Gordon, et al. demonstrated that 66 of these human host proteins are potential targets of known drugs used for other purposes, and that a subset of these drugs inhibit viral replication in vitro.
You can order all the clones encoding these human interacting proteins, either individually or as a complete library, in any of our 250+ non-viral or lentiviral vector types. To order complete libraries, please visit our ORF cDNA library page.
Related products
Webinars
Title: Advanced Tools For COVID-19 Coronavirus Research From GeneCopoeia Presented Wednesday, September 9, 2020 The COVID-19 global pandemic, caused by the SARS-CoV-2 coronavirus, highlights an urgent need for diagnostic reagents, antiviral therapeutics, and vaccine development. In this webinar, we will discuss GeneCopoeia’s advanced solutions including testing kits, SARS-CoV-2 pseudotyped virus, and other tools needed for research into combating this deadly disease. Watch recorded webinar / Download slidesPublications
View selected publications citing GeneCopoeia’s COVID-19 coronavirus plasmid clones from the recent literature- Fernandes, M.F., et al. (2022). Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene1 responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein. bioRxiv doi: 10.1101/2022.01.11.475901 [OMICSLINK™ SARS-CoV-2 ORF8, ORF10, and M ORF expression clones]
- Zhang, L., et al. (2022). Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein. Critical Care doi: 10.1186/s13054-022-04034-9 [OMICSLINK™ ACE2, SARS-CoV-2 Spike ORF expression clones]
- Minenkova, O., et al. (2022). Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy. Molecular Therapy doi: 10.1016/j.ymthe.2022.02.013 [OMICSLINK™ SARS-CoV-2 Spike alpha, beta, and gamma ORF expression clones]
- Ostrov, D.A., et al. (2022).Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. Pathogens doi: 10.3390/pathogens10111514 [OMICSLINK™ ACE2 lentiviral ORF expression clone]
- Riccio, A., et al. (2022). Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence. Cellular and Molecular Life Sciences doi: 10.1007/s00018-022-04246-w [OMICSLINK™ SARS-CoV-2 Spike alpha, beta, and gamma ORF expression clones]
- He, C-L., et al. (2022). Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products in vitro. bioRxiv doi: 10.1101/2020.12.13.420406 [OMICSLINK™ ACE2, DPP4 ORF expression clones]
- Kasopefoluwa, Y., et al. (2022). Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio doi: 10.1128/mBio.02492 [OMICSLINK™ ACE2, TMPRSS2 lentiviral ORF expression clones]
- Hu, J., et al. (2022). Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera. Genes & Diseases doi: 10.1016/j.gendis.2021.11.007 [OMICSLINK™ ACE2 ORF expression clone]
- Capcha, J.M.C., et al. (2022). Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Frontiers in Cardiovascular Medicine doi: 10.3389/fcvm.2020.618651 [OMICSLINK™ ACE2, TMPRSS2, Furin lentiviral ORF expression clones]
- Oguntuyo, K.Y., et al. (2021). Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio doi: 0.1128/mBio.02492-20 [OMICSLINK™ ACE2, TMPRSS2 lentiviral ORF expression clones]
- Lempp, F.A., et al. (2021). Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature doi: 10.1038/s41586-021-03925-1 [OMICSLINK™ DC-SIGN (CD209), L-SIGN (CLEC4M), SIGLEC1, TMPRSS2 or ACE2 lentiviral ORF expression clone]
- Hu, J., et al. (2020). Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2. Genes & Diseases doi: 10.1016/j.gendis.2020.07.006 [OMICSLINK™ ACE2 ORF expression clone]
- Capcha, J.M.C., et al. (2020). Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Frontiers in Cardiovascular Medicine doi: 10.3389/fcvm.2020.618651 [OMICSLINK™ ACE2, TMPRSS2, Furin lentiviral ORF expression clones]






